Clinical efficacy of nivolumab-based therapy for HER2-negative diffuse-type advanced gastric or gastroesophageal junction adenocarcinoma with peritoneal dissemination by Y. Suzuki, K. Shimozaki, S. Udagawa, K. Chin, H. Osumi, S. Fukuoka, K. Yoshino, M. Tamba, T. Wakatsuki, M. Ogura, E. Shinozaki, K. Yamaguchi, A. Ooki

Get full text

Managing zolbetuximab-induced nausea and vomiting: a proposal for a pragmatic approach in clinical practice by K. Shimozaki, A. Ooki, Y. Yamahata, T. Aoyama, K. Yoshino, M. Tamba, S. Udagawa, S. Fukuoka, H. Osumi, T. Wakatsuki, E. Shinozaki, M. Ogura, K. Chin, K. Yamaguchi

Get full text

Real-world outcomes of trifluridine/tipiracil for heavily pretreated patients with advanced gastric cancer by K. Fukuda, I. Nakayama, A. Ooki, D. Kamiimabeppu, K. Shimozaki, H. Osumi, S. Fukuoka, K. Yoshino, M. Ogura, T. Wakatsuki, K. Chin, E. Shinozaki, K. Yamaguchi, D. Takahari

Get full text

Safety and efficacy of first-line nivolumab plus chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: real-world data analysis by K. Shimozaki, K. Fukuda, A. Ooki, I. Nakayama, K. Yoshino, M. Tamba, S. Udagawa, S. Fukuoka, H. Osumi, T. Wakatsuki, D. Takahari, E. Shinozaki, M. Ogura, K. Chin, K. Yamaguchi

Get full text